Altrafin AG’s Cognizant CTSH Stock Holding History

Altrafin AG’s Portfolio CTSH Stock Details CTSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$675K	–	74
2022 Q2	$675K	Hold	10,000	–	–	0.36%	56
2022 Q1	$897K	Sell	10,000 -1,500	-13%	-$132K	0.35%	57
2021 Q4	$1.02M	Buy	+11,500	New	+$925K	0.37%	58

Other funds holding CTSH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Altrafin AG's CTSH Position: Q3 2022 in Review

Altrafin AG sold out of Cognizant (CTSH) in Q3 2022, closing a stake of 10,000 shares — an estimated $675K sold.

Altrafin AG first reported a position in CTSH in Q4 2021 and held it in 3 quarters. The position peaked at $1.02M in Q4 2021. 890 funds tracked by Wall St. Rank hold CTSH as of Q3 2022.

Altrafin AG reported no remaining Cognizant position as of Q3 2022 after selling out during the quarter.
Altrafin AG sold 10,000 Cognizant shares in Q3 2022, an estimated $675K.
Altrafin AG first reported a position in Cognizant in Q4 2021 and held it in 3 quarters.
Altrafin AG's Cognizant position peaked at $1.02M in Q4 2021.
890 funds tracked by Wall St. Rank held Cognizant as of Q3 2022.

Based on Altrafin AG's 13F filing for Q3 2022, filed 17 Feb 2026.